BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 21254343)

  • 1. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume.
    Garcia-Martinez R; Rovira A; Alonso J; Jacas C; Simón-Talero M; Chavarria L; Vargas V; Córdoba J
    Liver Transpl; 2011 Jan; 17(1):38-46. PubMed ID: 21254343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased white matter lesion volume and improved cognitive function after liver transplantation.
    Rovira A; Mínguez B; Aymerich FX; Jacas C; Huerga E; Córdoba J; Alonso J
    Hepatology; 2007 Nov; 46(5):1485-90. PubMed ID: 17929307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation significantly improves global functioning and cerebral processing.
    Ahluwalia V; Wade JB; White MB; Gilles HS; Heuman DM; Fuchs M; Gavis EA; Fagan A; Tinsley F; Ganapathy D; Thacker LR; Sterling RK; Stravitz RT; Puri P; Sanyal AJ; Siddiqui MS; Matherly S; Luketic V; Steinberg J; Moeller FG; Bajaj JS
    Liver Transpl; 2016 Oct; 22(10):1379-90. PubMed ID: 27339647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation.
    Mechtcheriakov S; Graziadei IW; Mattedi M; Bodner T; Kugener A; Hinterhuber HH; Marksteiner J; Vogel W
    Liver Transpl; 2004 Jan; 10(1):77-83. PubMed ID: 14755782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
    Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
    Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
    Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
    Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
    Guevara M; Baccaro ME; Torre A; Gómez-Ansón B; Ríos J; Torres F; Rami L; Monté-Rubio GC; Martín-Llahí M; Arroyo V; Ginès P
    Am J Gastroenterol; 2009 Jun; 104(6):1382-9. PubMed ID: 19455124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
    Mathiesen HK; Jonsson A; Tscherning T; Hanson LG; Andresen J; Blinkenberg M; Paulson OB; Sorensen PS
    Arch Neurol; 2006 Apr; 63(4):533-6. PubMed ID: 16606765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
    Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
    Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.
    Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE
    Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts.
    Kramer L; Bauer E; Gendo A; Funk G; Madl C; Pidlich J; Gangl A
    Am J Gastroenterol; 2002 Jan; 97(1):162-6. PubMed ID: 11808942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus.
    Filley CM; Kozora E; Brown MS; Miller DE; West SG; Arciniegas DB; Grimm A; Zhang L
    Cogn Behav Neurol; 2009 Mar; 22(1):38-44. PubMed ID: 19372769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
    van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
    Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
    Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
    J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
    Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
    Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation.
    Sotil EU; Gottstein J; Ayala E; Randolph C; Blei AT
    Liver Transpl; 2009 Feb; 15(2):184-92. PubMed ID: 19177446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
    Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A
    Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New assessment of hepatic encephalopathy.
    Córdoba J
    J Hepatol; 2011 May; 54(5):1030-40. PubMed ID: 21145874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.